Drug Safety
Subscribe to Drug Safety

The Lead

Diabetes Drug Spurs Weight Loss, But Not Without Side Effects

July 2, 2015 12:30 pm | by Stephanie Guzowski, Editor | News | Comments

The injectable drug liraglutide, marketed as Saxenda, can help overweight or obese patients lose a significant amount of weight — but a study in the New England Journal of Medicine reports that the drug also carries several side effects. Read more...

Statins Linked to Lower Aggression in Men, But Higher in Women

July 2, 2015 10:11 am | by University of California - San Diego | News | Comments

Statins are a hugely popular drug class used to manage blood cholesterol levels and reduce the...

One in Four People Prescribed Opioids Progressed to Longer-Term Prescriptions

July 2, 2015 9:56 am | by Mayo Clinic | News | Comments

Opioid painkiller addiction and accidental overdoses have become far too common across the...

Trends in Antipsychotic Medication Use in Children, Adolescents, and Young Adults

July 2, 2015 9:22 am | by Columbia University | News | Comments

Despite concerns that use of antipsychotic medications in treating young people has increased,...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Bowel Cancer Risk Reduced by Taking Aspirin for Lynch Syndrome Patients

July 1, 2015 4:09 pm | by University of Melbourne | News | Comments

This is the largest study to date investigating the associations between aspirin, ibuprofen and bowel cancer risk for people with Lynch syndrome. Read more...

Oxycontin Maker Bows Out of Meeting on Harder-to-Abuse Drug

July 1, 2015 10:02 am | by Matthew Perrone, AP Health Writer - Associated Press | News | Comments

The makers of the potent painkiller OxyContin have pulled out of a federal meeting to review the company's harder-to-abuse version of the much-debated drug. Read more...

NIH Begins Clinical Trial of New Medication for Alcohol Use Disorder

June 25, 2015 12:02 pm | by NIH | News | Comments

A clinical trial investigating a potential treatment for alcohol use disorder (AUD) was announced by the National Institute of Alcohol Abuse and Alcoholism (NIAAA). The study will assess the safety and efficacy of gabapentin enacarbil (HORIZANT) in extended-release tablets for treating moderate to severe AUD. NIAAA is part of the National Institutes of Health. Read more...


Model Could Help Counteract Poisoning from Popular Painkiller

June 24, 2015 8:55 am | by Duke University | News | Comments

New research could help reverse deadly side effects caused by excessive doses of the drug acetaminophen, the major ingredient in Tylenol and many other over-the-counter and prescription medicines. Read more...

Viagra Does Something Very Important—But It Is Unlikely to Cause Melanoma, Researchers Conclude

June 23, 2015 1:08 pm | by New York University School of Medicine | News | Comments

A rigorous analysis of more than 20,000 medical records concludes that erectile dysfunction drugs, such as Viagra, are not a cause of melanoma, an often deadly form of skin cancer, despite the higher risk for the disease among users of these drugs. Read more...

Study: Scant Evidence That Medical Pot Helps Many Illnesses

June 23, 2015 1:01 pm | by By Lindsey Tanner, AP Medical Writer | News | Comments

Medical marijuana has not been proven to work for many illnesses that state laws have approved it for, according to the first comprehensive analysis of research on its potential benefits. Read more...

Small, Potentially Significant Link between Heartburn Drugs, Heart Attacks

June 23, 2015 9:43 am | by Cynthia Fox, Science Editor | Articles | Comments

By data-mining untapped clinician notes, Stanford University researchers found the heartburn drug class that includes Prilosec and Prevacid is associated with a small, but potentially significant, heart attack risk, even among the healthy, says a new study in PLOS One. Prilosec and Prevacid are proton pump inhibitors (PPIs). PPIs are the third-most prescribed drugs in the U.S. Read more...

Merck Biochemist Arrested, Charged with Running GHB Lab in His Home

June 22, 2015 1:11 pm | by Seth Augenstein, Digital Reporter | News | Comments

A senior biochemist at Merck was arrested last week and charged with running a drug lab at his home, authorities announced. Read more...


Research Team Issued Patent for New Anesthesia Monitoring Technology

June 18, 2015 11:45 am | by Wayne State University | News | Comments

While anesthesia has gotten much safer over the years, there is still a need for improved health monitoring systems during surgery. Read more...

Brain Receptor Found to Significantly Affect Cocaine Addiction

June 18, 2015 11:33 am | by University of Buffalo | News | Comments

Discovery of new neural pathway may lead to preventing relapses in addicts. Read more...

Pfizer Reports Top Line Results from Phase 3 Study of Pristiq

June 15, 2015 8:22 am | News | Comments

The drug was evaluated for the efficacy, safety, and tolerability in pediatric patients ages 7 to 17 with Major Depressive Disorder. Read more...

Drug Discovery Spotlight: FDA Recommendation for Praluent, Repatha; Identifying Past Viral Infections

June 12, 2015 11:29 am | by Stephanie Guzowski, Editor | News | Comments

Two new cholesterol-lowering drugs, in a class their own, were FDA recommended this week and now, await approval. And a reasonably priced, new blood test can reveal a lifetime’s worth of viral infections. Read more...

Statins Don’t Harm Memory After All, Suggests Million-Patient Study

June 12, 2015 10:09 am | by Cynthia Fox, Science Editor | Articles | Comments

Statins, popular cholesterol lowering drugs, do not appear to cause short-term memory loss after all, according to a large recent study in JAMA Internal Medicine. The study, which looked at some one million patients, indicated past memory-loss reports may have been hampered by detection bias, as both statin users and users of non-statin lipid lowering drugs (LLDs) reported some memory loss. Read more...


FDA Recommends Approval for GSK's Severe Asthma Drug for Adults

June 12, 2015 9:05 am | News | Comments

The Committee voted against approval of mepolizumab for use in adolescents 12-17 years of age with severe asthma. Read more...

Diabetes Drug Sitagliptin Shows No Increased Risk Of Heart Events

June 11, 2015 10:15 am | by Duke University | News | Comments

A clinical trial of the glucose-control drug sitagliptin among patients with type 2 diabetes and established cardiovascular disease has found it did not raise the risk of major adverse cardiovascular events. Read more...

EULAR 2015: Pfizer to Present New Data on Xeljanz

June 11, 2015 9:04 am | News | Comments

Highlights include over six-years of safety and efficacy data from two long-term extension studies. Read more...

Mylan Expands Voluntary Recall of Select Injectable Products

June 10, 2015 12:16 pm | by Ryan Bushey, Associate Editor | Articles | Comments

This medication could cause severe health problems if administered when infected with an unknown pollutant. Read more...

FDA Panel Recommends Approval of New Cholesterol-Lowering Drug

June 10, 2015 11:25 am | by Stephanie Guzowski, Editor | News | Comments

A Food and Drug Administration (FDA) advisory panel on Tuesday recommended approval of a new injectable drug, alirocumab (Praluent) from Sanofi SA and Regeneron Pharmaceuticals, to help prevent heart attacks by lowering cholesterol. The new drug may be more powerful and carry fewer side effects than statins. Read more...

Limiting Genetic Tests for Breast Cancer Susceptibility

June 8, 2015 8:20 am | by McGill University | News | Comments

Screening for genes whose risk association with breast cancer has yet to be proven is not justified and potentially harmful. Read more...

Using Diamond to Identify Counterfeit Drugs

June 4, 2015 8:50 am | by Dr. Andrew S. Janoff, Founder and CEO, Taaneh, Inc. | Articles | Comments

In countries around the world, the sale of counterfeit drugs is a significant problem for the pharmaceutical industry. It is estimated that global sales of counterfeit drugs now total more than $350 billion every year. In addition to lost revenue for drug marketers, falsified drugs also pose a significant risk to the safety and well being of consumers. Read more...

Researcher: Controversial Stop-Smoking Drug Champix is Safe

June 1, 2015 4:28 pm | by University of Adelaide | News | Comments

The controversial smoking cessation drug Champix has been linked to suicidal side-effects but, according to a leading Adelaide respiratory researcher, Champix is safe and can improve someone’s chances of kicking the habit. Read more...

Immunotherapy Drugs Show Continued Promise

June 1, 2015 4:16 pm | by Cancer Research UK | News | Comments

The drugs, known as checkpoint inhibitors, are designed to overcome cancer’s ability to hide from the body’s immune system. Read more...

ASCO 2015 Highlights

June 1, 2015 2:05 pm | by Stephanie Guzowski, Editor | News | Comments

Here are some of the top news coming out of the American Society of Clinical Oncology (ASCO) Annual Meeting. Read more...

MDMA, aka Ecstasy, May Be New Treatment for Autism’s Social Anxiety

May 29, 2015 12:34 pm | by Seth Augenstein, Digital Reporter | News | Comments

A recreational drug known for making people uninhibited and getting them dancing in clubs could get a new use: to help treat social anxiety among autistic adults, according to a new proposal by a group of researchers. Read more...

Sanofi, Regeneron Annouce Positive Phase 3 Data for Arthritis Drug

May 27, 2015 9:26 am | News | Comments

No unexpected safety findings were observed.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.